Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

ISSN: 2253-1556

Journal Articles:

- 147 records -

Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

Ferrara CA, La Rocca G, Ielo G, Libra A, Sambataro G

ImmunoTargets and Therapy 2023, 12:79-89

Published Date: 26 July 2023

Novel Immunotherapies for Myasthenia Gravis

Nair SS, Jacob S

ImmunoTargets and Therapy 2023, 12:25-45

Published Date: 4 April 2023

Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Wang X, Guo Z, Wu X, Chen D, Wang F, Yang L, Luo M, Wu S, Yang C, Huang L, Fu L

ImmunoTargets and Therapy 2023, 12:1-16

Published Date: 4 January 2023

The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome

Macdougall JD, Thomas KO, Iweala OI

ImmunoTargets and Therapy 2022, 11:37-54

Published Date: 15 September 2022

Immunotargets and Therapy for Prurigo Nodularis

Labib A, Ju T, Vander Does A, Yosipovitch G

ImmunoTargets and Therapy 2022, 11:11-21

Published Date: 26 April 2022

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma

Lin AY, Schnitter JM, Gordon LI

ImmunoTargets and Therapy 2022, 11:1-10

Published Date: 23 February 2022

Pathophysiology of Non-IgE-Mediated Food Allergy

Zhang S, Sicherer S, Berin MC, Agyemang A

ImmunoTargets and Therapy 2021, 10:431-446

Published Date: 29 December 2021

Understanding and Managing Severe Asthma in the Context of COVID-19

Kong-Cardoso B, Ribeiro A, Aguiar R, Pité H, Morais-Almeida M

ImmunoTargets and Therapy 2021, 10:419-430

Published Date: 11 December 2021

The Role of IL-17 Cytokines in Psoriasis

Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T

ImmunoTargets and Therapy 2021, 10:409-418

Published Date: 24 November 2021

The Role of Complement in Synaptic Pruning and Neurodegeneration

Gomez-Arboledas A, Acharya MM, Tenner AJ

ImmunoTargets and Therapy 2021, 10:373-386

Published Date: 24 September 2021

Immunotherapy of Multiple Myeloma: Promise and Challenges

Abramson HN

ImmunoTargets and Therapy 2021, 10:343-371

Published Date: 9 September 2021

Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis

Arneson LC, Carroll KJ, Ruderman EM

ImmunoTargets and Therapy 2021, 10:333-342

Published Date: 28 August 2021

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma

Bughda R, Dimou P, D'Souza RR, Klampatsa A

ImmunoTargets and Therapy 2021, 10:313-323

Published Date: 5 August 2021

Alopecia Areata: An Autoimmune Disease of Multiple Players

Suchonwanit P, Kositkuljorn C, Pomsoong C

ImmunoTargets and Therapy 2021, 10:299-312

Published Date: 29 July 2021

Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology

Unterberger S, Davies KA, Rambhatla SB, Sacre S

ImmunoTargets and Therapy 2021, 10:285-298

Published Date: 28 July 2021

Complement Inhibition and COVID-19: The Story so Far

Fodil S, Annane D

ImmunoTargets and Therapy 2021, 10:273-284

Published Date: 26 July 2021

Cannabis and Autoimmunity: Possible Mechanisms of Action

Giorgi V, Marotto D, Batticciotto A, Atzeni F, Bongiovanni S, Sarzi-Puttini P

ImmunoTargets and Therapy 2021, 10:261-271

Published Date: 21 July 2021

The Cancer-Immunity Cycle in Multiple Myeloma

Casey M, Nakamura K

ImmunoTargets and Therapy 2021, 10:247-260

Published Date: 16 July 2021

Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era

Kasarello K, Mirowska-Guzel D

ImmunoTargets and Therapy 2021, 10:237-246

Published Date: 7 July 2021

Targeting CD22 for the Treatment of B-Cell Malignancies

Shah NN, Sokol L

ImmunoTargets and Therapy 2021, 10:225-236

Published Date: 6 July 2021

CD38-Directed Therapies for Management of Multiple Myeloma

Hashmi H, Husnain M, Khan A, Usmani SZ

ImmunoTargets and Therapy 2021, 10:201-211

Published Date: 29 June 2021

VISTA: A Promising Target for Cancer Immunotherapy?

Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M

ImmunoTargets and Therapy 2021, 10:185-200

Published Date: 22 June 2021

Memory Generation and Re-Activation in Food Allergy

Koenig JFE, Bruton K, Phelps A, Grydziuszko E, Jiménez-Saiz R, Jordana M

ImmunoTargets and Therapy 2021, 10:171-184

Published Date: 9 June 2021

NHS-IL12, a Tumor-Targeting Immunocytokine

Greiner JW, Morillon II YM, Schlom J

ImmunoTargets and Therapy 2021, 10:155-169

Published Date: 27 May 2021

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

Atzeni F, Carriero A, Boccassini L, D'Angelo S

ImmunoTargets and Therapy 2021, 10:141-153

Published Date: 3 May 2021

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

Xu N, Tse B, Yang L, Tang TCY, Haber M, Micklethwaite K, Dolnikov A

ImmunoTargets and Therapy 2021, 10:123-140

Published Date: 28 April 2021

TNFR2: Role in Cancer Immunology and Immunotherapy

Yang Y, Islam MS, Hu Y, Chen X

ImmunoTargets and Therapy 2021, 10:103-122

Published Date: 21 April 2021

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches

Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F

ImmunoTargets and Therapy 2021, 10:63-85

Published Date: 9 March 2021

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent

Barros PO, Berthoud TK, Aloufi N, Angel JB

ImmunoTargets and Therapy 2021, 10:47-62

Published Date: 8 March 2021

Anti-IgE for the Treatment of Chronic Urticaria

Wedi B, Traidl S

ImmunoTargets and Therapy 2021, 10:27-45

Published Date: 17 February 2021

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Passiglia F, Reale ML, Cetoretta V, Novello S

ImmunoTargets and Therapy 2021, 10:9-26

Published Date: 5 February 2021

Current Insights into Immunotherapy Approaches for Food Allergy

Macdougall JD, Burks AW, Kim EH

ImmunoTargets and Therapy 2021, 10:1-8

Published Date: 27 January 2021

IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity

van Gool MMJ, van Egmond M

ImmunoTargets and Therapy 2020, 9:351-372

Published Date: 5 January 2021

Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery

Horkowitz AP, Schwartz AV, Alvarez CA, Herrera EB, Thoman ML, Chatfield DA, Osborn KG, Feuer R, George UZ, Phillips JA

ImmunoTargets and Therapy 2020, 9:333-350

Published Date: 17 December 2020

Complement Inhibition for the Treatment of Myasthenia Gravis

Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P

ImmunoTargets and Therapy 2020, 9:317-331

Published Date: 15 December 2020

Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications

Lillo AM, Velappan N, Kelliher JM, Watts AJ, Merriman SP, Vuyisich G, Lilley LM, Coombs KE, Mastren T, Teshima M, Stein BW, Wagner GL, Iyer S, Bradbury ARM, Harris JF, Dichosa AE, Kozimor SA

ImmunoTargets and Therapy 2020, 9:299-316

Published Date: 27 November 2020

Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma

Sepe P, Mennitto A, Corti F, Procopio G

ImmunoTargets and Therapy 2020, 9:273-288

Published Date: 13 November 2020

Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR

ImmunoTargets and Therapy 2020, 9:255-272

Published Date: 10 November 2020

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

Tanaka Y, Hoshino-Negishi K, Kuboi Y, Tago F, Yasuda N, Imai T

ImmunoTargets and Therapy 2020, 9:241-253

Published Date: 4 November 2020

More articles